| scholarly article | Q13442814 |
| P50 | author | Reza Dana | Q16206939 |
| P2093 | author name string | Sunil K Chauhan | |
| Sunali Goyal | |||
| P2860 | cites work | Prevalence of dry eye syndrome among US women | Q28196875 |
| Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration | Q33432580 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| Homing and cellular traffic in lymph nodes | Q34282818 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? | Q34952967 | ||
| Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function | Q35607278 | ||
| Development of the lymphatic vascular system: a mystery unravels | Q35891280 | ||
| Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis | Q36371903 | ||
| Tumor and lymph node lymphangiogenesis--impact on cancer metastasis | Q36515932 | ||
| Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players | Q36952220 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Mediators of ocular angiogenesis | Q37678807 | ||
| VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 | ||
| The crucial role of macrophages in lymphangiogenesis | Q41945366 | ||
| Alterations of ocular surface gene expression in Sjögren's syndrome. | Q42457018 | ||
| Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
| Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. | Q45930063 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease | Q46209348 | ||
| The controlled-environment chamber: a new mouse model of dry eye. | Q46618772 | ||
| Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival | Q57706454 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation | Q79704928 | ||
| Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) | Q80347923 | ||
| Lymphangiogenesis in development and disease | Q80774020 | ||
| The economic burden of dry eye: a conceptual framework and preliminary assessment | Q80902614 | ||
| Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma | Q84287383 | ||
| The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis | Q84558483 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 84-89 | |
| P577 | publication date | 2011-09-12 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease | |
| P478 | volume | 130 |
| Q38886086 | Ageing and ocular surface immunity. |
| Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
| Q36601706 | Comparison of postoperative corneal changes between dry eye and non-dry eye in a murine cataract surgery model |
| Q34881185 | Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity |
| Q64097915 | Corneal lymphangiogenesis ameliorates corneal inflammation and edema in late stage of bacterial keratitis |
| Q39404635 | Dry Eye Management: Targeting the Ocular Surface Microenvironment. |
| Q37485819 | Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization |
| Q55112422 | Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. |
| Q36044544 | Efficacy of topical blockade of interleukin-1 in experimental dry eye disease |
| Q35754989 | Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q35672575 | Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease |
| Q34028408 | Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q36799205 | Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3. |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q37581630 | Recent developments on dry eye disease treatment compounds |
| Q27001612 | Receptor tyrosine kinase-mediated angiogenesis |
| Q92918329 | TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis |
| Q35145988 | The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation |
| Q37953774 | The lymphatic vasculature in disease |
| Q41244028 | Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
| Q35921437 | Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis |
Search more.